Status:

COMPLETED

Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.

Lead Sponsor:

Johannes Gutenberg University Mainz

Collaborating Sponsors:

Deutsche Krebshilfe e.V., Bonn (Germany)

Conditions:

Oropharyngeal Cancer

Oral Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Radiotherapy with or without adjuvant chemotherapy represents an important column of modern therapy in advanced squamous cell originated tumours of the head and neck. However to date no studies are av...

Detailed Description

Background Prevailing curative intended therapeutic strategies combine radical resection of the tumor mass with a safety margin followed by radiation of the original tumor site and adjacent locoregio...

Eligibility Criteria

Inclusion

  • histological diagnosis of a primary squamous cell carcinoma of the oral cavity or the oropharynx
  • maximum tumor diameter less than 4 cm in the pathohistological specimen irrespective of histological grading (pT1 or pT2)
  • concomitant histological verification of a singular ipsilateral lymph node metastasis less than 3cm in diameter (pN1) without penetration of the lymph node´s capsule and without presence of invasion of lymphatic vessels (lymphangiosis carcinomatosa)
  • radical resection of the tumor within adequate resection margins (R0)
  • written informed consent from the patient
  • adequate performance status ECOG Index ≤ 2

Exclusion

  • an age less than 18 years old
  • pregnant women
  • reported drug addiction
  • intake of remedies with potential influence on compliance or impaired judgment
  • patients with mental disorders or conceivable physical, familial or job related embarrassments which may preclude the patient to realize the study schedule
  • inadequate performance status ECOG Index \> 2

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2021

Estimated Enrollment :

209 Patients enrolled

Trial Details

Trial ID

NCT00964977

Start Date

October 1 2009

End Date

December 1 2021

Last Update

February 25 2022

Active Locations (49)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 13 (49 locations)

1

Universiätsklinikum Tübingen

Tübingen, Baden-Wurttemberg, Germany

2

Universitätsklinikum Erlangen

Erlangen, Bavaria, Germany

3

Universitätsklinik München

München, Bavaria, Germany

4

Universität Regensburg

Regensburg, Bavaria, Germany, 93053